Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Once-weekly treatment of tuberculosis with the diarylquinoline R207910: a real possibility.

× No keyword cloud information.

6 in total

Review 1. TMC207: the first compound of a new class of potent anti-tuberculosis drugs.

Authors: Alberto Matteelli; Anna Cc Carvalho; Kelly E Dooley; Afranio Kritski
Journal: Future Microbiol Date: 2010-06 Impact factor: 3.165

Review 2. Current development and future prospects in chemotherapy of tuberculosis.

Authors: Eric L Nuermberger; Melvin K Spigelman; Wing Wai Yew
Journal: Respirology Date: 2010-06-04 Impact factor: 6.424

Review 3. New drugs and regimens for treatment of TB.

Authors: Eric Leibert; William N Rom
Journal: Expert Rev Anti Infect Ther Date: 2010-07 Impact factor: 5.091

4. Activities of TMC207, rifampin, and pyrazinamide against Mycobacterium tuberculosis infection in guinea pigs.

Authors: Shaobin Shang; Crystal A Shanley; Megan L Caraway; Eileen A Orme; Marcela Henao-Tamayo; Laurel Hascall-Dove; David Ackart; Anne J Lenaerts; Randall J Basaraba; Ian M Orme; Diane J Ordway
Journal: Antimicrob Agents Chemother Date: 2010-10-11 Impact factor: 5.191

5. The diarylquinoline R207910 is bactericidal against Mycobacterium leprae in mice at low dose and administered intermittently.

Authors: Robert Gelber; Koen Andries; Rose Maria D Paredes; Cora Evelyn S Andaya; Jasmin Burgos
Journal: Antimicrob Agents Chemother Date: 2009-07-13 Impact factor: 5.191

Review 6. New drugs to treat multidrug-resistant tuberculosis: the case for bedaquiline.

Authors: Eric Leibert; Mauricio Danckers; William N Rom
Journal: Ther Clin Risk Manag Date: 2014-07-29 Impact factor: 2.423

6 in total